Dawnrays Pharmaceutical (Holdings) Gestione
Gestione criteri di controllo 2/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Liwei Yu
Amministratore delegato
n/a
Compenso totale
| Percentuale dello stipendio del CEO | n/a |
| Mandato del CEO | less than a year |
| Proprietà del CEO | n/a |
| Durata media del management | 18.2yrs |
| Durata media del Consiglio di amministrazione | 16.5yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Earnings Might Not Be As Promising As They Seem
Sep 21
Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.015
Sep 11Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.065
May 25Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of CN¥0.065
Apr 22Dawnrays Pharmaceutical (Holdings) (HKG:2348) Has Announced A Dividend Of CN¥0.065
Apr 08Dawnrays Pharmaceutical (Holdings) (HKG:2348) Is Due To Pay A Dividend Of CN¥0.065
Mar 25Dawnrays Pharmaceutical (Holdings) (HKG:2348) Has Announced A Dividend Of CN¥0.015
Aug 30Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Shareholders Will Receive A Bigger Dividend Than Last Year
May 26Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of CN¥0.073
Apr 04Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.015
Sep 19Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Solid Profits Have Weak Fundamentals
Sep 22Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of HK$0.015
Sep 12Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be HK$0.015
Aug 29Here's How We Evaluate Dawnrays Pharmaceutical (Holdings) Limited's (HKG:2348) Dividend
Feb 28Would Shareholders Who Purchased Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Stock Five Years Be Happy With The Share price Today?
Feb 07
Yung Lai Hung Is The Co-Founder & Executive Director of Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348) And They Just Picked Up 34% More Shares
Jan 14Dawnrays Pharmaceutical (Holdings) Limited's (HKG:2348) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Dec 22What Kind Of Investors Own Most Of Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)?
Dec 09Three Things You Should Check Before Buying Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348) For Its Dividend
Nov 23AMMINISTRATORE DELEGATO
Liwei Yu (54 yo)
less than a year
Mandato
Ms. Liwei Yu is Chief Executive Officer of Dawnrays Pharmaceutical (Holdings) Limited from September 13, 2024. Ms. Yu is the Chief Human Resources Officer of the Group and fully responsible for the human r...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 22.1yrs | CN¥1.05m | 7.15% HK$ 132.1m | |
| Co-Founder & Executive Director | 29.8yrs | CN¥672.00k | 0.13% HK$ 2.3m | |
| Chief Executive Officer | less than a year | Nessun dato | Nessun dato | |
| Chief Financial Officer | 6.6yrs | Nessun dato | Nessun dato | |
| Company Secretary | no data | Nessun dato | Nessun dato |
18.2yrs
Durata media
60yo
Età media
Gestione esperta: Il team dirigenziale di 2348 è esperto e expertise (durata media dell'incarico 18.2 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 22.1yrs | CN¥1.05m | 7.15% HK$ 132.1m | |
| Co-Founder & Executive Director | 22.1yrs | CN¥672.00k | 0.13% HK$ 2.3m | |
| Independent Non-Executive Director | 9.4yrs | CN¥326.00k | Nessun dato | |
| Non-Executive Director | 19yrs | CN¥271.00k | Nessun dato | |
| Independent Non-Executive Director | 14.1yrs | CN¥326.00k | Nessun dato | |
| Independent Non-Executive Director | 6.5yrs | CN¥326.00k | Nessun dato |
16.5yrs
Durata media
60.5yo
Età media
Consiglio di amministrazione esperto: Il consiglio di amministrazione di 2348 è composto da personale esperto e esperto (durata media dell'incarico 16.5 anni).